Report Library
View More
Datamonitor Healthcare CV&Met Disea...
December 1, 2023
Inflammatory Bowel Disease (IBD) KO...
November 30, 2023
Datamonitor Healthcare CV&Met Disea...
November 29, 2023
Datamonitor Healthcare Oncology: Ac...
November 28, 2023
Datamonitor Healthcare Oncology: Ga...
November 28, 2023
Datamonitor Healthcare CNS: Hunting...
November 28, 2023
Datamonitor Healthcare Oncology Dis...
November 24, 2023
Datamonitor Healthcare Oncology Dis...
November 23, 2023
Datamonitor Healthcare I&I: Systemi...
November 23, 2023
Datamonitor Healthcare Infectious D...
November 23, 2023
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 11/29/23 | BioVie (BIVI) | NE3107 for Alzheimer's Disease (AD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/29/23 | BiomX (PHGE) | BX004 for Cystic Fibrosis (CF) | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/29/23 | AbbVie (ABBV) | Telisotuzumab Vedotin for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/27/23 | Aldeyra (ALDX) | Reproxalap for Dry Eye (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/27/23 | Xenon Pharmaceutials (XENE) | XEN1101 for Major Depressive Disorder (MDD) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 11/30/23 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 12/02/23 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 12/02/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 12/02/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 12/02/23 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
